Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.
C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype.
Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer.
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases. Magn Reson Imaging. 2020 06; 69:49-56.
View in:
PubMed
subject areas
Adult
Aged
Algorithms
Area Under Curve
Brain Neoplasms
DNA Mutational Analysis
ErbB Receptors
Female
Humans
Lung Neoplasms
Magnetic Resonance Imaging
Male
Middle Aged
Mutation
Neoplasm Metastasis
Prognosis
Proto-Oncogene Proteins p21(ras)
Retrospective Studies
authors with profiles
Ravi Salgia